EP Patent

EP0361977A2 — Peptides having T cell suppressor activity

Assigned to Immunobiology Research Institute Inc · Expires 1990-04-04 · 36y expired

What this patent protects

Peptides having the biological activity of the mole­cule human thymopentin, namely the ability to increase cGMP activity in human T-cell line CEM, have the formula R-Arg-X-Asp-Y-NR¹R² wherein R is H, lower alkyl, acetyl, formyl lower alkanoyl; X is Pro, dehydro-Pro, hydroxyl-…

USPTO Abstract

Peptides having the biological activity of the mole­cule human thymopentin, namely the ability to increase cGMP activity in human T-cell line CEM, have the formula R-Arg-X-Asp-Y-NR¹R² wherein R is H, lower alkyl, acetyl, formyl lower alkanoyl; X is Pro, dehydro-Pro, hydroxyl-Pro, D-Lys, Aib or Lys; Y is Gly or a D or L form of an amino acid selected from Val, Ala, Ile, Leu, Asp, Glu, Gln or Lys; R¹ is H and R² is lower alkyl or alkenyl having 1 to 10 carbon atoms, cyclic alkyl or alkenyl having 4 to 8 carbon atoms, aryl or NHR³, where R³ is a lower alkyl having 1 to 10 carbon atoms, cyclic alkyl or alkenyl having 4 to 8 carbon atoms, or aryl; or R¹ and R² together comprise a methylene chain of 4 to 7 carbon atoms. These peptides can be used in pharmaceutical compo­sitions for regulating a deficiency or excess of T-cell function in human subjects.

Drugs covered by this patent

Patent Metadata

Patent number
EP0361977A2
Jurisdiction
EP
Classification
Expires
1990-04-04
Drug substance claim
No
Drug product claim
No
Assignee
Immunobiology Research Institute Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.